We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

THERMO FISHER SCIENTIFIC

Thermo Fisher Scientific provides analytical instruments, lab equipment, specialty diagnostics, reagents and integrat... read more Featured Products: More products

Download Mobile App




Highly Sensitive Detection Method Monitors HDL Kinetics

By LabMedica International staff writers
Posted on 28 Apr 2016
Print article
Image: The Q Exactive hybrid quadrupole orbitrap mass spectrometer (Photo courtesy of Thermo Fisher Scientific).
Image: The Q Exactive hybrid quadrupole orbitrap mass spectrometer (Photo courtesy of Thermo Fisher Scientific).
High-density lipoprotein (HDL) is often referred to as good cholesterol, and high levels of HDL are associated with lower risk of cardiovascular disease, but many clinical outcome trials for drugs that raise HDL levels have failed to show significant benefits for trial participants.

Current HDL detection methods usually measure only total HDL cholesterol, but a more sensitive detection method could allow investigators to measure the subfractions of HDL, and more precisely pinpoint which of these subfractions should be raised to help protect against cardiovascular events.

Scientists at Brigham and Women's Hospital (Boston, MA, USA) and their colleagues studied three participants, two female and one male who were ages 25, 33, and 49 years old; were overweight or obese with a body mass index (BMI) of 26, 31, and 31 kg/m2; and had low HDL-C levels of 48, 37, and 24 mg/dl, respectively. The three participants ate a controlled, high-unsaturated-fat diet for 32 days, 28 days prior to the kinetic study, and four days during the kinetic study.

Total plasma leucine (D3-Leu labeled and endogenous) was isolated from 0.2 mL of plasma from different time points and measured using a Gas Chromatograph/ Mass Spectrometer (GC/MS) 6890 GC, 5973 MS, (Agilent Technologies, Santa Clara, CA, USA). HDL was separated by size using nondenaturing polyacrylamide gel electrophoresis (ND-PAGE). Spectral counting was used for the relative quantification of the apolipoproteins. Peptide samples were analyzed with the Q Exactive mass spectrometer fronted with a Nanospray FLEX ion source, and coupled to an Easy-nLC1000 High performance liquid chromatography (HPLC) pump (Thermo Fisher Scientific, Bremen, Germany).

The investigators were able to identify 58 proteins in HDL that were shared among three participants. They followed up on seven of these proteins, monitoring their kinetics to better understand apolipoprotein metabolism and the formation of HDL particles. Their results suggest that the traditional view of the role of HDL in reverse cholesterol transport may oversimplify the roles and contributions of various components of HDL.

The authors concluded that their study demonstrated the feasibility of closer monitoring of HDL kinetics. They believe that establishing new, high-resolution methods that can monitor HDL kinetics is critical to examine the desired effects of new drugs. This approach not only revealed novel evidence for the formation of HDL particles, but also found that each HDL subfraction has a unique proteome, which may help to discover new therapeutic targets. The study was published on April 1, 2016, in Journal of Lipid Research.

Related Links:
Brigham and Women's Hospital
Agilent Technologies
Thermo Fisher Scientific
Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Piezoelectric Micropump
Disc Pump
New
TORCH Infections Test
TORCH Panel

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.